Vance Thompson, MD, Refractive editor, discusses highlights of the section and how this issue is “a wonderful invitation to our extended family in ophthalmology and a representation of important topics that will be represented at the Annual Meeting.”
Enhanced monofocal and “ringless” EDOFs are a couple of the names floating around for a newer type of IOL designed to extend depth of focus while maintaining, as much as possible, the quality of distance vision provided by a monofocal IOL. This article explores physician experience with these new IOL options.
When choosing the best refractive surgery option, there are a variety of factors that surgeons consider, including patient age, overall goals, and expectations. Three surgeons discussed which procedures they use and some of the specifics of laser refractive surgery, phakic IOLs, and lens replacement surgery.
Though it has been available in the U.S. for a fraction of time compared to the well-established laser vision correction procedures PRK and LASIK, SMILE has quickly become the dominant procedure in the practices of many refractive surgeons.
Clara Chan, MD, Cornea editor, shared an experience that emphasizes the value patient history can have on a diagnosis, in this case recurrent subconjunctival hemorrhages from conjunctivochalasis, which is the focus of an article in the section, as well as other issue highlights.
While in recent months mask use has been relaxed somewhat as health guidelines are updated to reflect increased vaccination status and declining case numbers, there are situations where mask wear continues. These have been credited with playing a role in saving lives, but they have been associated with some unintended ocular consequences as well.
Underdiagnosed, often neglected, and much more common than clinicians realize is how some physicians describe conjunctivochalasis. This article is a deep dive into the condition, its diagnosis, and management options.
Numerous studies have looked at different approaches to using bevacizumab and other anti-VEGF agents for anterior segment surgery. Several experts discussed their use and study of bevacizumab, particularly relating to corneal neovascularization and in corneal transplants.
Keratoprosthesis is an active area of research and development with recent innovations and updates to some devices in the keratoprosthesis field as a whole.
Ophthalmology will see its first major live meeting since the pandemic started with the 2021 ASCRS Annual Meeting. “Just as the live meeting will be reflective of our interesting times, this issue of EyeWorld is a product of our unique year, covering many topics that will help the modern ophthalmologist and glaucoma specialist succeed,” said Nathan Radcliffe, MD, Glaucoma editor.